Home » Topics » Regulatory

Regulatory
RSS

Sucampo licenses tacrolimus from Fujisawa for ophthalmic use

Feb. 21, 2002

sNDA submitted for Prevacid in pediatric patients

Feb. 21, 2002

Commonly used antibiotic shows potential for Rx of multiple sclerosis

Feb. 21, 2002

Aciphex indications expanded

Feb. 19, 2002

Eisai seeks FDA clearance for new indication of Aciphex/Pariet

Feb. 15, 2002

Clarinex approved by FDA for perennial allergic rhinitis and chronic idiopathic urticaria

Feb. 14, 2002

Launch of delayed-release oral suspension formulation of Prevacid

Feb. 13, 2002

Xenical approved in Canada for use in type 2 diabetics

Feb. 13, 2002

Tracleer fails to meet primary endpoints in phase III CHF study

Feb. 12, 2002

BMS and Sanofi-Synthelabo withdraw irbesartan sNDA

Feb. 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...